What are the contraindications for Terbinafine (oral antifungal medication) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Contraindications for Oral Terbinafine

Oral terbinafine is absolutely contraindicated in patients with a history of allergic reaction to the drug due to anaphylaxis risk, and should not be used in patients with active or chronic liver disease. 1, 2

Absolute Contraindications

  • History of hypersensitivity or allergic reaction to terbinafine is the only FDA-labeled absolute contraindication due to risk of anaphylaxis 1

  • Serious hypersensitivity reactions documented with terbinafine include Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS syndrome, making any prior severe cutaneous reaction an absolute contraindication 2, 3

  • Active or chronic liver disease represents a strong clinical contraindication, as terbinafine is explicitly not recommended in these patients by the British Association of Dermatologists 2, 3

    • While one case report describes successful use in stable autoimmune hepatitis with extensive precautions 4, this should be considered exceptional rather than standard practice
    • The FDA warns that liver failure leading to transplant or death has occurred with oral terbinafine 1

Relative Contraindications and High-Risk Populations

  • Severe renal impairment is a practical contraindication because terbinafine clearance is significantly decreased in severe kidney disease 2, 3

    • Terbinafine is primarily cleared by the kidneys, and the British Association of Dermatologists explicitly lists renal impairment as a contraindication rather than recommending dose adjustment 3
  • Pediatric onychomycosis represents an unlicensed indication requiring baseline monitoring if use is considered 2, 3

Mandatory Baseline Monitoring Before Initiation

If terbinafine must be used despite concerns, baseline liver function tests and complete blood count are mandatory in the following populations 2, 3:

  • History of heavy alcohol consumption
  • History of hepatitis
  • Hematological abnormalities
  • Pediatric patients (as terbinafine is not licensed for pediatric onychomycosis)

Critical Patient Counseling Requirements

  • Taste and smell disturbances can be permanent, requiring explicit patient counseling before initiation 2, 3, 1

    • The FDA recommends discontinuing terbinafine if taste or smell disturbance occurs 1
    • These disturbances may be severe, prolonged, or permanent 3, 1
  • Severe neutropenia has been reported; terbinafine should be discontinued if neutrophil count drops to ≤1,000 cells/mm³ 1

  • Depressive symptoms have been reported with terbinafine use, requiring vigilance for development of mood changes 1

References

Guideline

Contraindications to Oral Terbinafine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Terbinafine Safety Profile

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can a patient undergo a second course of terbinafine therapy if the first course was completed without adverse reactions and liver function is normal?
What is the risk of liver injury associated with terbinafine 250 mg taken once daily in an adult patient without known liver disease?
At what point should terbinafine (an antifungal medication) be discontinued in a patient with elevated liver enzymes, particularly those with pre-existing liver conditions or taking other hepatotoxic medications?
What is the recommended schedule for monitoring liver function tests (and other labs) in a patient taking oral terbinafine, including baseline testing and follow‑up intervals, and how should this be adjusted for risk factors such as pre‑existing liver disease, heavy alcohol use, or concurrent hepatotoxic medications?
What are the risks associated with oral terbinafine (antifungal medication)?
At what creatinine level do you consider a patient to have severe renal insufficiency?
Can glucagon help with a foreign body obstruction in the throat?
What is the lowest effective dose of trizeptide?
Are procedures 37765 and 37766 (Stab Phlebectomy) medically necessary for a patient with varicosity on the back of their left leg, who has failed conservative treatment and has symptoms of pain, throbbing, and achiness?
What is the appropriate management for a patient with a confirmed Baker cyst, bed bug infestation, and liver function abnormalities, who is planning international travel?
What is the management approach for a patient with elevated ferritin, leukopenia (low White Blood Cell count), and neutropenia (low neutrophil count)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.